SCHEMBL31455225

SCHEMBL31455225

COC(=O)c1ccc(Nc2nc(-c3ccccc3)ccc2N)cc1F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
CASP3 P42574 1/20 0.44
SENP8 Q96LD8 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44
ABCG2 Q9UNQ0 3/20 0.42
PDE5A O76074 2/20 0.42
ABCC1 P33527 1/20 0.42
ALDH1A1 P00352 6/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
KDM4E B2RXH2 3/20 0.40
PLA2G2A P14555 1/20 0.40
MAP2K3 P46734 1/20 0.40
MAPT P10636 4/20 0.39
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.39
SYK P43405 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31455719 0.83 ABCG2 (0.45) NPC1RAB9ASMN1; SMN2CASP3SENP8
SCHEMBL31227501 0.82 ABL1 (0.44) ALDH1A1KDM4EMAPTGAAHPGD
SCHEMBL25385310 0.82 ABCG2 (0.61) SMN1; SMN2ABCG2PDE5AABCC1ALDH1A1
SCHEMBL31455169 0.82 ABCG2 (0.61) SMN1; SMN2ABCG2PDE5AABCC1ALDH1A1
SCHEMBL31455120 0.78 PDE5A (0.43) NPC1RAB9ASMN1; SMN2ABCG2PDE5A
SCHEMBL31455275 0.78 BRD9 (0.43) SMN1; SMN2ABCG2MEN1KMT2AMAP2K3
SCHEMBL16608985 0.76 MAPT (0.55) NPC1RAB9ASMN1; SMN2CASP3SENP8
SCHEMBL31455688 0.76 ABCG2 (0.39) ABCG2SYKHDAC1
SCHEMBL31455924 0.76 HDAC2 (0.41) NPC1RAB9ASMN1; SMN2ABCG2PDE5A
SCHEMBL16645313 0.75 HDAC1 (0.57) RAB9ASMN1; SMN2ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025059577-A1 SUBSTITUTED AMINOPYRIDINE COMPOUNDS FOR USE AS AKT1 INHIBITORS ATAVISTIK BIO, INC. (US) 2025-03-20 WO disclosed